Table of Content

1 PDE Inhibitors Market Overview
1.1 PDE Inhibitors Product Scope
1.2 PDE Inhibitors Segment by Type
1.2.1 Global PDE Inhibitors Sales by Type (2016 & 2021 & 2027)
1.2.2 PDE5
1.2.3 PDE4
1.2.4 Viagra
1.2.5 Cialis
1.2.6 Levitra
1.2.7 Others
1.3 PDE Inhibitors Segment by Application
1.3.1 Global PDE Inhibitors Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Genitourinary
1.3.3 Cardiovascular Diseases
1.3.4 Dermatological Disorders
1.3.5 Respiratory Diseases
1.3.6 Schizophrenia
1.3.7 Alzheimer’S Disease
1.3.8 Huntington’S Disease
1.3.9 Others
1.4 PDE Inhibitors Market Estimates and Forecasts (2016-2027)
1.4.1 Global PDE Inhibitors Market Size in Value Growth Rate (2016-2027)
1.4.2 Global PDE Inhibitors Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global PDE Inhibitors Price Trends (2016-2027)

2 PDE Inhibitors Estimates and Forecasts by Region
2.1 Global PDE Inhibitors Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global PDE Inhibitors Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global PDE Inhibitors Sales Market Share by Region (2016-2021)
2.2.2 Global PDE Inhibitors Revenue Market Share by Region (2016-2021)
2.3 Global PDE Inhibitors Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global PDE Inhibitors Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global PDE Inhibitors Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America PDE Inhibitors Estimates and Projections (2016-2027)
2.4.2 Europe PDE Inhibitors Estimates and Projections (2016-2027)
2.4.3 China PDE Inhibitors Estimates and Projections (2016-2027)
2.4.4 Japan PDE Inhibitors Estimates and Projections (2016-2027)
2.4.5 Southeast Asia PDE Inhibitors Estimates and Projections (2016-2027)
2.4.6 India PDE Inhibitors Estimates and Projections (2016-2027)

3 Global PDE Inhibitors Competition Landscape by Players
3.1 Global Top PDE Inhibitors Players by Sales (2016-2021)
3.2 Global Top PDE Inhibitors Players by Revenue (2016-2021)
3.3 Global PDE Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PDE Inhibitors as of 2020)
3.4 Global PDE Inhibitors Average Price by Company (2016-2021)
3.5 Manufacturers PDE Inhibitors Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global PDE Inhibitors Market Size by Type
4.1 Global PDE Inhibitors Historic Market Review by Type (2016-2021)
4.1.1 Global PDE Inhibitors Sales Market Share by Type (2016-2021)
4.1.2 Global PDE Inhibitors Revenue Market Share by Type (2016-2021)
4.1.3 Global PDE Inhibitors Price by Type (2016-2021)
4.2 Global PDE Inhibitors Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global PDE Inhibitors Sales Forecast by Type (2022-2027)
4.2.2 Global PDE Inhibitors Revenue Forecast by Type (2022-2027)
4.2.3 Global PDE Inhibitors Price Forecast by Type (2022-2027)

5 Global PDE Inhibitors Market Size by Application
5.1 Global PDE Inhibitors Historic Market Review by Application (2016-2021)
5.1.1 Global PDE Inhibitors Sales Market Share by Application (2016-2021)
5.1.2 Global PDE Inhibitors Revenue Market Share by Application (2016-2021)
5.1.3 Global PDE Inhibitors Price by Application (2016-2021)
5.2 Global PDE Inhibitors Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global PDE Inhibitors Sales Forecast by Application (2022-2027)
5.2.2 Global PDE Inhibitors Revenue Forecast by Application (2022-2027)
5.2.3 Global PDE Inhibitors Price Forecast by Application (2022-2027)

6 North America PDE Inhibitors Market Facts & Figures
6.1 North America PDE Inhibitors Sales by Company
6.1.1 North America PDE Inhibitors Sales by Company (2016-2021)
6.1.2 North America PDE Inhibitors Revenue by Company (2016-2021)
6.2 North America PDE Inhibitors Sales Breakdown by Type
6.2.1 North America PDE Inhibitors Sales Breakdown by Type (2016-2021)
6.2.2 North America PDE Inhibitors Sales Breakdown by Type (2022-2027)
6.3 North America PDE Inhibitors Sales Breakdown by Application
6.3.1 North America PDE Inhibitors Sales Breakdown by Application (2016-2021)
6.3.2 North America PDE Inhibitors Sales Breakdown by Application (2022-2027)

7 Europe PDE Inhibitors Market Facts & Figures
7.1 Europe PDE Inhibitors Sales by Company
7.1.1 Europe PDE Inhibitors Sales by Company (2016-2021)
7.1.2 Europe PDE Inhibitors Revenue by Company (2016-2021)
7.2 Europe PDE Inhibitors Sales Breakdown by Type
7.2.1 Europe PDE Inhibitors Sales Breakdown by Type (2016-2021)
7.2.2 Europe PDE Inhibitors Sales Breakdown by Type (2022-2027)
7.3 Europe PDE Inhibitors Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)

8 China PDE Inhibitors Market Facts & Figures
8.1 China PDE Inhibitors Sales by Company
8.1.1 China PDE Inhibitors Sales by Company (2016-2021)
8.1.2 China PDE Inhibitors Revenue by Company (2016-2021)
8.2 China PDE Inhibitors Sales Breakdown by Type
8.2.1 China PDE Inhibitors Sales Breakdown by Type (2016-2021)
8.2.2 China PDE Inhibitors Sales Breakdown by Type (2022-2027)
8.3 China PDE Inhibitors Sales Breakdown by Application
8.3.1 China 172 Sales Breakdown by Application (2016-2021)
8.3.2 China 172 Sales Breakdown by Application (2022-2027)

9 Japan PDE Inhibitors Market Facts & Figures
9.1 Japan PDE Inhibitors Sales by Company
9.1.1 Japan PDE Inhibitors Sales by Company (2016-2021)
9.1.2 Japan PDE Inhibitors Revenue by Company (2016-2021)
9.2 Japan PDE Inhibitors Sales Breakdown by Type
9.2.1 Japan PDE Inhibitors Sales Breakdown by Type (2016-2021)
9.2.2 Japan PDE Inhibitors Sales Breakdown by Type (2022-2027)
9.3 Japan PDE Inhibitors Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia PDE Inhibitors Market Facts & Figures
10.1 Southeast Asia PDE Inhibitors Sales by Company
10.1.1 Southeast Asia PDE Inhibitors Sales by Company (2016-2021)
10.1.2 Southeast Asia PDE Inhibitors Revenue by Company (2016-2021)
10.2 Southeast Asia PDE Inhibitors Sales Breakdown by Type
10.2.1 Southeast Asia PDE Inhibitors Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia PDE Inhibitors Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia PDE Inhibitors Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India PDE Inhibitors Market Facts & Figures
11.1 India PDE Inhibitors Sales by Company
11.1.1 India PDE Inhibitors Sales by Company (2016-2021)
11.1.2 India PDE Inhibitors Revenue by Company (2016-2021)
11.2 India PDE Inhibitors Sales Breakdown by Type
11.2.1 India PDE Inhibitors Sales Breakdown by Type (2016-2021)
11.2.2 India PDE Inhibitors Sales Breakdown by Type (2022-2027)
11.3 India PDE Inhibitors Sales Breakdown by Application
11.3.1 India PDE Inhibitors Sales Breakdown by Application (2016-2021)
11.3.2 India PDE Inhibitors Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in PDE Inhibitors Business
12.1 Hanmi Science Holding
12.1.1 Hanmi Science Holding Corporation Information
12.1.2 Hanmi Science Holding Business Overview
12.1.3 Hanmi Science Holding PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Hanmi Science Holding PDE Inhibitors Products Offered
12.1.5 Hanmi Science Holding Recent Development
12.2 Boehringer Ingelheim
12.2.1 Boehringer Ingelheim Corporation Information
12.2.2 Boehringer Ingelheim Business Overview
12.2.3 Boehringer Ingelheim PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Boehringer Ingelheim PDE Inhibitors Products Offered
12.2.5 Boehringer Ingelheim Recent Development
12.3 Takeda Pharmaceuticals
12.3.1 Takeda Pharmaceuticals Corporation Information
12.3.2 Takeda Pharmaceuticals Business Overview
12.3.3 Takeda Pharmaceuticals PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Takeda Pharmaceuticals PDE Inhibitors Products Offered
12.3.5 Takeda Pharmaceuticals Recent Development
12.4 AstraZeneca
12.4.1 AstraZeneca Corporation Information
12.4.2 AstraZeneca Business Overview
12.4.3 AstraZeneca PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.4.4 AstraZeneca PDE Inhibitors Products Offered
12.4.5 AstraZeneca Recent Development
12.5 Bayer
12.5.1 Bayer Corporation Information
12.5.2 Bayer Business Overview
12.5.3 Bayer PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bayer PDE Inhibitors Products Offered
12.5.5 Bayer Recent Development
12.6 Celgene
12.6.1 Celgene Corporation Information
12.6.2 Celgene Business Overview
12.6.3 Celgene PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Celgene PDE Inhibitors Products Offered
12.6.5 Celgene Recent Development
12.7 Eli Lilly
12.7.1 Eli Lilly Corporation Information
12.7.2 Eli Lilly Business Overview
12.7.3 Eli Lilly PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Eli Lilly PDE Inhibitors Products Offered
12.7.5 Eli Lilly Recent Development
12.8 Pfizer
12.8.1 Pfizer Corporation Information
12.8.2 Pfizer Business Overview
12.8.3 Pfizer PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Pfizer PDE Inhibitors Products Offered
12.8.5 Pfizer Recent Development
12.9 BioCrea
12.9.1 BioCrea Corporation Information
12.9.2 BioCrea Business Overview
12.9.3 BioCrea PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.9.4 BioCrea PDE Inhibitors Products Offered
12.9.5 BioCrea Recent Development
12.10 Dart NeuroScience
12.10.1 Dart NeuroScience Corporation Information
12.10.2 Dart NeuroScience Business Overview
12.10.3 Dart NeuroScience PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Dart NeuroScience PDE Inhibitors Products Offered
12.10.5 Dart NeuroScience Recent Development
12.11 Carinopharm
12.11.1 Carinopharm Corporation Information
12.11.2 Carinopharm Business Overview
12.11.3 Carinopharm PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Carinopharm PDE Inhibitors Products Offered
12.11.5 Carinopharm Recent Development
12.12 CTC Bio
12.12.1 CTC Bio Corporation Information
12.12.2 CTC Bio Business Overview
12.12.3 CTC Bio PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.12.4 CTC Bio PDE Inhibitors Products Offered
12.12.5 CTC Bio Recent Development
12.13 FORUM Pharmaceuticals
12.13.1 FORUM Pharmaceuticals Corporation Information
12.13.2 FORUM Pharmaceuticals Business Overview
12.13.3 FORUM Pharmaceuticals PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.13.4 FORUM Pharmaceuticals PDE Inhibitors Products Offered
12.13.5 FORUM Pharmaceuticals Recent Development
12.14 Intra-Cellular Therapies
12.14.1 Intra-Cellular Therapies Corporation Information
12.14.2 Intra-Cellular Therapies Business Overview
12.14.3 Intra-Cellular Therapies PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Intra-Cellular Therapies PDE Inhibitors Products Offered
12.14.5 Intra-Cellular Therapies Recent Development
12.15 Omeros Corporation
12.15.1 Omeros Corporation Corporation Information
12.15.2 Omeros Corporation Business Overview
12.15.3 Omeros Corporation PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Omeros Corporation PDE Inhibitors Products Offered
12.15.5 Omeros Corporation Recent Development
12.16 Medimetriks Pharmaceuticals
12.16.1 Medimetriks Pharmaceuticals Corporation Information
12.16.2 Medimetriks Pharmaceuticals Business Overview
12.16.3 Medimetriks Pharmaceuticals PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Medimetriks Pharmaceuticals PDE Inhibitors Products Offered
12.16.5 Medimetriks Pharmaceuticals Recent Development
12.17 NuSirt Biopharma
12.17.1 NuSirt Biopharma Corporation Information
12.17.2 NuSirt Biopharma Business Overview
12.17.3 NuSirt Biopharma PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.17.4 NuSirt Biopharma PDE Inhibitors Products Offered
12.17.5 NuSirt Biopharma Recent Development
12.18 Palobiopharma
12.18.1 Palobiopharma Corporation Information
12.18.2 Palobiopharma Business Overview
12.18.3 Palobiopharma PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Palobiopharma PDE Inhibitors Products Offered
12.18.5 Palobiopharma Recent Development
12.19 Roivant Sciences
12.19.1 Roivant Sciences Corporation Information
12.19.2 Roivant Sciences Business Overview
12.19.3 Roivant Sciences PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Roivant Sciences PDE Inhibitors Products Offered
12.19.5 Roivant Sciences Recent Development
12.20 Sagene Pharmaceuticals
12.20.1 Sagene Pharmaceuticals Corporation Information
12.20.2 Sagene Pharmaceuticals Business Overview
12.20.3 Sagene Pharmaceuticals PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Sagene Pharmaceuticals PDE Inhibitors Products Offered
12.20.5 Sagene Pharmaceuticals Recent Development
12.21 Tetra Discovery Partners
12.21.1 Tetra Discovery Partners Corporation Information
12.21.2 Tetra Discovery Partners Business Overview
12.21.3 Tetra Discovery Partners PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Tetra Discovery Partners PDE Inhibitors Products Offered
12.21.5 Tetra Discovery Partners Recent Development
12.22 Tritech Biopharm
12.22.1 Tritech Biopharm Corporation Information
12.22.2 Tritech Biopharm Business Overview
12.22.3 Tritech Biopharm PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Tritech Biopharm PDE Inhibitors Products Offered
12.22.5 Tritech Biopharm Recent Development
12.23 Otsuka
12.23.1 Otsuka Corporation Information
12.23.2 Otsuka Business Overview
12.23.3 Otsuka PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Otsuka PDE Inhibitors Products Offered
12.23.5 Otsuka Recent Development
12.24 Chiesi Farmaceutici
12.24.1 Chiesi Farmaceutici Corporation Information
12.24.2 Chiesi Farmaceutici Business Overview
12.24.3 Chiesi Farmaceutici PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Chiesi Farmaceutici PDE Inhibitors Products Offered
12.24.5 Chiesi Farmaceutici Recent Development
12.25 Verona Pharma
12.25.1 Verona Pharma Corporation Information
12.25.2 Verona Pharma Business Overview
12.25.3 Verona Pharma PDE Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.25.4 Verona Pharma PDE Inhibitors Products Offered
12.25.5 Verona Pharma Recent Development

13 PDE Inhibitors Manufacturing Cost Analysis
13.1 PDE Inhibitors Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of PDE Inhibitors
13.4 PDE Inhibitors Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 PDE Inhibitors Distributors List
14.3 PDE Inhibitors Customers

15 Market Dynamics
15.1 PDE Inhibitors Market Trends
15.2 PDE Inhibitors Drivers
15.3 PDE Inhibitors Market Challenges
15.4 PDE Inhibitors Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global PDE Inhibitors Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global PDE Inhibitors Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global PDE Inhibitors Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global PDE Inhibitors Sales (K Units) by Region (2016-2021)
Table 5. Global PDE Inhibitors Sales Market Share by Region (2016-2021)
Table 6. Global PDE Inhibitors Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global PDE Inhibitors Revenue Share by Region (2016-2021)
Table 8. Global PDE Inhibitors Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global PDE Inhibitors Sales Market Share Forecast by Region (2022-2027)
Table 10. Global PDE Inhibitors Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global PDE Inhibitors Revenue Share Forecast by Region (2022-2027)
Table 12. Global PDE Inhibitors Sales (K Units) of Key Companies (2016-2021)
Table 13. Global PDE Inhibitors Sales Share by Company (2016-2021)
Table 14. Global PDE Inhibitors Revenue (US$ Million) by Company (2016-2021)
Table 15. Global PDE Inhibitors Revenue Share by Company (2016-2021)
Table 16. Global PDE Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PDE Inhibitors as of 2020)
Table 17. Global PDE Inhibitors Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers PDE Inhibitors Manufacturing Sites and Area Served
Table 19. Manufacturers PDE Inhibitors Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global PDE Inhibitors Sales (K Units) by Type (2016-2021)
Table 22. Global PDE Inhibitors Sales Share by Type (2016-2021)
Table 23. Global PDE Inhibitors Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global PDE Inhibitors Price (USD/Unit) by Type (2016-2021)
Table 25. Global PDE Inhibitors Sales Share by Type (2022-2027)
Table 26. Global PDE Inhibitors Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global PDE Inhibitors Revenue Share by Type (2022-2027)
Table 28. Global PDE Inhibitors Price (USD/Unit) by Type (2022-2027)
Table 29. Global PDE Inhibitors Sales (K Units) by Application (2016-2021)
Table 30. Global PDE Inhibitors Sales Share by Application (2016-2021)
Table 31. Global PDE Inhibitors Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global PDE Inhibitors Price (USD/Unit) by Application (2016-2021)
Table 33. Global PDE Inhibitors Sales (K Units) by Application (2022-2027)
Table 34. Global PDE Inhibitors Sales Share by Application (2022-2027)
Table 35. Global PDE Inhibitors Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global PDE Inhibitors Revenue Share by Application (2022-2027)
Table 37. Global PDE Inhibitors Price (USD/Unit) by Application (2022-2027)
Table 38. North America PDE Inhibitors Sales (K Units) by Company (2016-2021)
Table 39. North America PDE Inhibitors Sales Market Share by Company (2016-2021)
Table 40. North America PDE Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America PDE Inhibitors Revenue Market Share by Company (2016-2021)
Table 42. North America PDE Inhibitors Sales by Type (2016-2021) & (K Units)
Table 43. North America PDE Inhibitors Sales Market Share by Type (2016-2021)
Table 44. North America PDE Inhibitors Sales by Type (2022-2027) & (K Units)
Table 45. North America PDE Inhibitors Sales Market Share by Type (2022-2027)
Table 46. North America PDE Inhibitors Sales by Application (2016-2021) & (K Units)
Table 47. North America PDE Inhibitors Sales Market Share by Application (2016-2021)
Table 48. North America PDE Inhibitors Sales by Application (2022-2027) & (K Units)
Table 49. North America PDE Inhibitors Sales Market Share by Application (2022-2027)
Table 50. Europe PDE Inhibitors Sales (K Units) by Company (2016-2021)
Table 51. Europe PDE Inhibitors Sales Market Share by Company (2016-2021)
Table 52. Europe PDE Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe PDE Inhibitors Revenue Market Share by Company (2016-2021)
Table 54. Europe PDE Inhibitors Sales by Type (2016-2021) & (K Units)
Table 55. Europe PDE Inhibitors Sales Market Share by Type (2016-2021)
Table 56. Europe PDE Inhibitors Sales by Type (2022-2027) & (K Units)
Table 57. Europe PDE Inhibitors Sales Market Share by Type (2022-2027)
Table 58. Europe PDE Inhibitors Sales by Application (2016-2021) & (K Units)
Table 59. Europe PDE Inhibitors Sales Market Share by Application (2016-2021)
Table 60. Europe PDE Inhibitors Sales by Application (2022-2027) & (K Units)
Table 61. Europe PDE Inhibitors Sales Market Share by Application (2022-2027)
Table 62. China PDE Inhibitors Sales (K Units) by Company (2016-2021)
Table 63. China PDE Inhibitors Sales Market Share by Company (2016-2021)
Table 64. China PDE Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 65. China PDE Inhibitors Revenue Market Share by Company (2016-2021)
Table 66. China PDE Inhibitors Sales by Type (2016-2021) & (K Units)
Table 67. China PDE Inhibitors Sales Market Share by Type (2016-2021)
Table 68. China PDE Inhibitors Sales by Type (2022-2027) & (K Units)
Table 69. China PDE Inhibitors Sales Market Share by Type (2022-2027)
Table 70. China PDE Inhibitors Sales by Application (2016-2021) & (K Units)
Table 71. China PDE Inhibitors Sales Market Share by Application (2016-2021)
Table 72. China PDE Inhibitors Sales by Application (2022-2027) & (K Units)
Table 73. China PDE Inhibitors Sales Market Share by Application (2022-2027)
Table 74. Japan PDE Inhibitors Sales (K Units) by Company (2016-2021)
Table 75. Japan PDE Inhibitors Sales Market Share by Company (2016-2021)
Table 76. Japan PDE Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan PDE Inhibitors Revenue Market Share by Company (2016-2021)
Table 78. Japan PDE Inhibitors Sales by Type (2016-2021) & (K Units)
Table 79. Japan PDE Inhibitors Sales Market Share by Type (2016-2021)
Table 80. Japan PDE Inhibitors Sales by Type (2022-2027) & (K Units)
Table 81. Japan PDE Inhibitors Sales Market Share by Type (2022-2027)
Table 82. Japan PDE Inhibitors Sales by Application (2016-2021) & (K Units)
Table 83. Japan PDE Inhibitors Sales Market Share by Application (2016-2021)
Table 84. Japan PDE Inhibitors Sales by Application (2022-2027) & (K Units)
Table 85. Japan PDE Inhibitors Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia PDE Inhibitors Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia PDE Inhibitors Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia PDE Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia PDE Inhibitors Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia PDE Inhibitors Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia PDE Inhibitors Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia PDE Inhibitors Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia PDE Inhibitors Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia PDE Inhibitors Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia PDE Inhibitors Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia PDE Inhibitors Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia PDE Inhibitors Sales Market Share by Application (2022-2027)
Table 98. India PDE Inhibitors Sales (K Units) by Company (2016-2021)
Table 99. India PDE Inhibitors Sales Market Share by Company (2016-2021)
Table 100. India PDE Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 101. India PDE Inhibitors Revenue Market Share by Company (2016-2021)
Table 102. India PDE Inhibitors Sales by Type (2016-2021) & (K Units)
Table 103. India PDE Inhibitors Sales Market Share by Type (2016-2021)
Table 104. India PDE Inhibitors Sales by Type (2022-2027) & (K Units)
Table 105. India PDE Inhibitors Sales Market Share by Type (2022-2027)
Table 106. India PDE Inhibitors Sales by Application (2016-2021) & (K Units)
Table 107. India PDE Inhibitors Sales Market Share by Application (2016-2021)
Table 108. India PDE Inhibitors Sales by Application (2022-2027) & (K Units)
Table 109. India PDE Inhibitors Sales Market Share by Application (2022-2027)
Table 110. Hanmi Science Holding Corporation Information
Table 111. Hanmi Science Holding Description and Business Overview
Table 112. Hanmi Science Holding PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Hanmi Science Holding PDE Inhibitors Product
Table 114. Hanmi Science Holding Recent Development
Table 115. Boehringer Ingelheim Corporation Information
Table 116. Boehringer Ingelheim Description and Business Overview
Table 117. Boehringer Ingelheim PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Boehringer Ingelheim PDE Inhibitors Product
Table 119. Boehringer Ingelheim Recent Development
Table 120. Takeda Pharmaceuticals Corporation Information
Table 121. Takeda Pharmaceuticals Description and Business Overview
Table 122. Takeda Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Takeda Pharmaceuticals PDE Inhibitors Product
Table 124. Takeda Pharmaceuticals Recent Development
Table 125. AstraZeneca Corporation Information
Table 126. AstraZeneca Description and Business Overview
Table 127. AstraZeneca PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. AstraZeneca PDE Inhibitors Product
Table 129. AstraZeneca Recent Development
Table 130. Bayer Corporation Information
Table 131. Bayer Description and Business Overview
Table 132. Bayer PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Bayer PDE Inhibitors Product
Table 134. Bayer Recent Development
Table 135. Celgene Corporation Information
Table 136. Celgene Description and Business Overview
Table 137. Celgene PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Celgene PDE Inhibitors Product
Table 139. Celgene Recent Development
Table 140. Eli Lilly Corporation Information
Table 141. Eli Lilly Description and Business Overview
Table 142. Eli Lilly PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Eli Lilly PDE Inhibitors Product
Table 144. Eli Lilly Recent Development
Table 145. Pfizer Corporation Information
Table 146. Pfizer PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Pfizer Description and Business Overview
Table 148. Pfizer PDE Inhibitors Product
Table 149. Pfizer Recent Development
Table 150. BioCrea Corporation Information
Table 151. BioCrea PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. BioCrea Description and Business Overview
Table 153. BioCrea PDE Inhibitors Product
Table 154. BioCrea Recent Development
Table 155. Dart NeuroScience Corporation Information
Table 156. Dart NeuroScience Description and Business Overview
Table 157. Dart NeuroScience PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Dart NeuroScience PDE Inhibitors Product
Table 159. Dart NeuroScience Recent Development
Table 160. Carinopharm Corporation Information
Table 161. Carinopharm Description and Business Overview
Table 162. Carinopharm PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Carinopharm PDE Inhibitors Product
Table 164. Carinopharm Recent Development
Table 165. CTC Bio Corporation Information
Table 166. CTC Bio Description and Business Overview
Table 167. CTC Bio PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. CTC Bio PDE Inhibitors Product
Table 169. CTC Bio Recent Development
Table 170. FORUM Pharmaceuticals Corporation Information
Table 171. FORUM Pharmaceuticals Description and Business Overview
Table 172. FORUM Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 173. FORUM Pharmaceuticals PDE Inhibitors Product
Table 174. FORUM Pharmaceuticals Recent Development
Table 175. Intra-Cellular Therapies Corporation Information
Table 176. Intra-Cellular Therapies Description and Business Overview
Table 177. Intra-Cellular Therapies PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 178. Intra-Cellular Therapies PDE Inhibitors Product
Table 179. Intra-Cellular Therapies Recent Development
Table 180. Omeros Corporation Corporation Information
Table 181. Omeros Corporation Description and Business Overview
Table 182. Omeros Corporation PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 183. Omeros Corporation PDE Inhibitors Product
Table 184. Omeros Corporation Recent Development
Table 185. Medimetriks Pharmaceuticals Corporation Information
Table 186. Medimetriks Pharmaceuticals Description and Business Overview
Table 187. Medimetriks Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 188. Medimetriks Pharmaceuticals PDE Inhibitors Product
Table 189. Medimetriks Pharmaceuticals Recent Development
Table 190. NuSirt Biopharma Corporation Information
Table 191. NuSirt Biopharma Description and Business Overview
Table 192. NuSirt Biopharma PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 193. NuSirt Biopharma PDE Inhibitors Product
Table 194. NuSirt Biopharma Recent Development
Table 195. Palobiopharma Corporation Information
Table 196. Palobiopharma Description and Business Overview
Table 197. Palobiopharma PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 198. Palobiopharma PDE Inhibitors Product
Table 199. Palobiopharma Recent Development
Table 200. Roivant Sciences Corporation Information
Table 201. Roivant Sciences Description and Business Overview
Table 202. Roivant Sciences PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 203. Roivant Sciences PDE Inhibitors Product
Table 204. Roivant Sciences Recent Development
Table 205. Sagene Pharmaceuticals Corporation Information
Table 206. Sagene Pharmaceuticals Description and Business Overview
Table 207. Sagene Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 208. Sagene Pharmaceuticals PDE Inhibitors Product
Table 209. Sagene Pharmaceuticals Recent Development
Table 210. Tetra Discovery Partners Corporation Information
Table 211. Tetra Discovery Partners Description and Business Overview
Table 212. Tetra Discovery Partners PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 213. Tetra Discovery Partners PDE Inhibitors Product
Table 214. Tetra Discovery Partners Recent Development
Table 215. Tritech Biopharm Corporation Information
Table 216. Tritech Biopharm Description and Business Overview
Table 217. Tritech Biopharm PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 218. Tritech Biopharm PDE Inhibitors Product
Table 219. Tritech Biopharm Recent Development
Table 220. Otsuka Corporation Information
Table 221. Otsuka Description and Business Overview
Table 222. Otsuka PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 223. Otsuka PDE Inhibitors Product
Table 224. Otsuka Recent Development
Table 225. Chiesi Farmaceutici Corporation Information
Table 226. Chiesi Farmaceutici Description and Business Overview
Table 227. Chiesi Farmaceutici PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 228. Chiesi Farmaceutici PDE Inhibitors Product
Table 229. Chiesi Farmaceutici Recent Development
Table 230. Verona Pharma Corporation Information
Table 231. Verona Pharma Description and Business Overview
Table 232. Verona Pharma PDE Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 233. Verona Pharma PDE Inhibitors Product
Table 234. Verona Pharma Recent Development
Table 235. Production Base and Market Concentration Rate of Raw Material
Table 236. Key Suppliers of Raw Materials
Table 237. PDE Inhibitors Distributors List
Table 238. PDE Inhibitors Customers List
Table 239. PDE Inhibitors Market Trends
Table 240. PDE Inhibitors Market Drivers
Table 241. PDE Inhibitors Market Challenges
Table 242. PDE Inhibitors Market Restraints
Table 243. Research Programs/Design for This Report
Table 244. Key Data Information from Secondary Sources
Table 245. Key Data Information from Primary Sources
List of Figures
Figure 1. PDE Inhibitors Product Picture
Figure 2. Global PDE Inhibitors Sales Market Share by Type in 2021 & 2027
Figure 3. PDE5 Product Picture
Figure 4. PDE4 Product Picture
Figure 5. Viagra Product Picture
Figure 6. Cialis Product Picture
Figure 7. Levitra Product Picture
Figure 8. Others Product Picture
Figure 9. Global PDE Inhibitors Sales Market Share by Application in 2021 & 2027
Figure 10. Genitourinary Examples
Figure 11. Cardiovascular Diseases Examples
Figure 12. Dermatological Disorders Examples
Figure 13. Respiratory Diseases Examples
Figure 14. Schizophrenia Examples
Figure 15. Alzheimer’S Disease Examples
Figure 16. Huntington’S Disease Examples
Figure 17. Others Examples
Figure 18. Global PDE Inhibitors Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global PDE Inhibitors Sales Growth Rate (2016-2027) & (US$ Million)
Figure 20. Global PDE Inhibitors Sales (K Units) Growth Rate (2016-2027)
Figure 21. Global PDE Inhibitors Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 22. Global PDE Inhibitors Revenue Market Share by Region: 2016 VS 2021
Figure 23. Global PDE Inhibitors Revenue Market Share by Region: 2021 VS 2027
Figure 24. North America PDE Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. North America PDE Inhibitors Sales (K Units) Growth Rate (2016-2027)
Figure 26. Europe PDE Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Europe PDE Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 28. China PDE Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. China PDE Inhibitors Sales (Million USD) and Growth Rate (2016-2027)
Figure 30. Japan PDE Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 31. Japan PDE Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 32. Southeast Asia PDE Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 33. Southeast Asia PDE Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 34. India PDE Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 35. India PDE Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 36. Global 5 Largest PDE Inhibitors Players Market Share by Revenue in PDE Inhibitors: 2016 & 2020
Figure 37. PDE Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 38. Global PDE Inhibitors Revenue Share by Type (2016-2021)
Figure 39. Global PDE Inhibitors Revenue Growth Rate by Type in 2016 & 2020
Figure 40. Global PDE Inhibitors Revenue Share by Application (2016-2021)
Figure 41. Global PDE Inhibitors Revenue Growth Rate by Application in 2016 & 2020
Figure 42. North America PDE Inhibitors Sales Market Share by Type in 2020
Figure 43. North America PDE Inhibitors Sales Market Share by Application in 2020
Figure 44. Europe PDE Inhibitors Sales Market Share by Type in 2020
Figure 45. Europe PDE Inhibitors Sales Market Share by Application in 2020
Figure 46. China PDE Inhibitors Sales Market Share by Type in 2020
Figure 47. China PDE Inhibitors Sales Market Share by Application in 2020
Figure 48. Japan PDE Inhibitors Sales Market Share by Type in 2020
Figure 49. Japan PDE Inhibitors Sales Market Share by Application in 2020
Figure 50. Southeast Asia PDE Inhibitors Sales Market Share by Type in 2020
Figure 51. Southeast Asia PDE Inhibitors Sales Market Share by Application in 2020
Figure 52. India PDE Inhibitors Sales Market Share by Type in 2020
Figure 53. India PDE Inhibitors Sales Market Share by Application in 2020
Figure 54. Key Raw Materials Price Trend
Figure 55. Manufacturing Cost Structure of PDE Inhibitors
Figure 56. Manufacturing Process Analysis of PDE Inhibitors
Figure 57. PDE Inhibitors Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed